Different amino acid replacements in CAAX-tetrapeptide based peptidomimetic farnesyltransferase inhibitors

Archiv der Pharmazie

Volumn 332, Issue 4, 1999, Pages 124-132

  Schlitzer, Martin ^a   Sattler, Isabel ^b   Dahse, Hans Martin ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Farnesyltransferase inhibitors; Peptidomimetics; Ras

Indexed keywords

2 ACYLAMINO 5 AMINOBENZOPHENONE DERIVATIVE; ANTINEOPLASTIC AGENT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; TETRAPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0032903678     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(19994)332:4<124::AID-ARDP124>3.0.CO;2-G     Document Type: Article

References (28)

1. P. J. Casey, M. C. Seabra, J. Biol. Chem. 1996, 271, 5289-5292.
2. D. M. Leonard, J. Med. Chem. 1997, 40, 2971-2990.
3. S. L. Graham, Exp. Opin. Ther. Patent 1995, 5, 1269-1285.
4. S. Ayral-Kaloustian, J. S. Skotnicki, Ann. Rep. Med. Chem. 1996, 171-180.
5. S. Clarke, Ann. Rev. Biochem. 1992, 61, 355-386.
6. A. D. Cox, C. J. Der, Biochim. Biophys. Acta 1997, 1333, F51-F71.
7. J. B. Gibbs, A. Oliff, Annu. Rev. Pharmacol. Toxicol. 1997, 37, 143-166.
8. M. Miyake, S. Mizutani, H. Koide, Y. Kaziro, FEBS Lett. 1996, 378, 15-18.
9. J. Sun, Y. Qian, A. D. Hamilton, S. M. Sebti, Oncogene 1998, 16, 1467-1473.
10. P. F. Lebowitz, D. Sakamuro, G. C. Prendergast, Cancer Res. 1997, 57, 807-813.
11. F. L. Zhang, P. J. Casey, Annu. Rev. Biochem. 1996, 65, 241-269.
12. K. Aoki, T. Yoshida, N. Matsumoto, H. Ide, T. Sugimura, M. Terada, Mol. Carcinog. 1997, 20, 251-258.
13. Y. Qian, M. A. Blaskovich, M. Saleem, C-M. Seong, S. P. Wathen, A. D. Hamilton, S. M. Sebti, J. Biol. Chem. 1994, 269, 12410-12413.
14. Y. Qian, A. Vogt, S. M. Sebti, A. D. Hamilton, J. Med. Chem. 1996, 39, 217-223.
15. T. Ciccarone, T. M. Williams, C. J. Dinsmore, G. E. Stokker, J. S. Wai (Merck & Co., INC). PCT WO 96/30014. 1996.
16. F. D. Bellamy, K. Ou, Tetrahedron Lett. 1984, 25, 839-841.
17. M. Svahn, F. Merenyi, L. Karlson, L. Widlund, M. Grälis, J. Med. Chem. 1986, 29, 448-453.
18. D. L. Pompliano, R. P. Gomez, N. J. Anthony, J. Am. Chem. Soc. 1992, 114, 7945-7946.
19. K. Del Villar, H. Mitsuzawa, W. Yang, I. Sattler, F. Tamanoi, J. Biol. Chem. 1997, 272, 680-687.
20. C. B. Lozzio, B. B. Lozzio Blood 1975, 45, 321-334.
21. J. W. Janssen, A. C. Steenvoorden, J. Lyons, B. Anger, J. U. Bohlke, J. L. Bos, H. Seliger, C. R. Bartram Proc. Acad. Sci. USA, 1987, 84, 9228-9232.
22. M. J. Murray, J. M. Cunningham, L. F. Parada, F. Dautry, P. Lebowitz, R. A. Weinberg Cell 1983, 33, 749-757.
23. Y. Qian, M. A. Blaskovich, C.-M. Seong, A. Vogt, A. D. Hamilton, S. M. Sebti, Bioorg. Med. Chem. Lett. 1994, 4, 2579-2584.
24. M. Schlitzer, unpublished results.
25. M. Schlitzer, I. Sattler, short communication presented at the annual meeting of the German Pharmaceutical Society, Tübingen, Nov. 6-8, 1998; Abstr.: Arch. Pharm. Med. Chem. 1998, 331, Suppl. 2, 30.
26. M. Schlitzer, I. Sattler, short communication presented at the annual meeting of the German Pharmaceutical Society, Tübingen, Nov. 6-8, 1998; Abstr.: Arch. Pharm. Med. Chem. 1998, 331, Suppl. 2, 30.
27. M. Schlitzer, I. Sattler, Angew. Chem., in press.
28. P. Winkelmeyer, B. Glauner, T. Lindl, ATLA 1993, 21, 269-280.